What’s going on?
Peloton reported worse-than-expected results late last week, as its audience’s devotion to the latest fitness fad once again ran out of steam.
What does this mean?
With gyms back in action last quarter, at-home exercise equipment fell out of favor and Peloton’s revenue growth dropped off dramatically. That, coupled with costs from an expensive treadmill recall, saw the company post a bigger-than-expected loss. It wasn’t optimistic about this quarter either: Peloton just slashed the price of its exercise bikes by around 20% in an attempt to get customers back on its saddles, and it’ll be shifting its business back toward less-profitable treadmills. And it’s a good thing Peloton likes to feel the burn, because this class isn’t over yet: the company also revealed it’d found a problem with the way it’s been valuing its inventory. That won’t change any of its previous financial reports, but it’s bound to make investors break out in a sweat…
Why should I care?
For markets: Someone get the Deep Heat.
Peloton had a heck of a run in 2020, with its shares rising more than 400% as people took to exercising at home during lockdown. But the company’s stock plummeted almost 10% on Friday after the disappointing results, which is just another painful cramp in a year full of them: Peloton’s lost more than 30% of its value this year.
The bigger picture: So much for a solo ride.
Even worse, Peloton – which as recently as last year had the “connected fitness” market all to itself – now has to go toe to toe with the likes of Hydrow, Tonal, and Lululemon-owned Mirror. And those chiseled rivals are already starting to push Peloton to its limits: last week’s exercise bike price cut was the second one in less than a year, and the company spent almost three times as much on sales and marketing last quarter compared to the same time last year.
Originally Posted on August 27, 2021 – Dead Trend
Disclosure: Interactive Brokers
Information posted on IBKR Traders’ Insight that is provided by third-parties and not by Interactive Brokers does NOT constitute a recommendation by Interactive Brokers that you should contract for the services of that third party. Third-party participants who contribute to IBKR Traders’ Insight are independent of Interactive Brokers and Interactive Brokers does not make any representations or warranties concerning the services offered, their past or future performance, or the accuracy of the information provided by the third party. Past performance is no guarantee of future results.
This material is from Finimize and is being posted with permission from Finimize. The views expressed in this material are solely those of the author and/or Finimize and IBKR is not endorsing or recommending any investment or trading discussed in the material. This material is not and should not be construed as an offer to sell or the solicitation of an offer to buy any security. To the extent that this material discusses general market activity, industry or sector trends or other broad based economic or political conditions, it should not be construed as research or investment advice. To the extent that it includes references to specific securities, commodities, currencies, or other instruments, those references do not constitute a recommendation to buy, sell or hold such security. This material does not and is not intended to take into account the particular financial conditions, investment objectives or requirements of individual customers. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.
In accordance with EU regulation: The statements in this document shall not be considered as an objective or independent explanation of the matters. Please note that this document (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and (b) is not subject to any prohibition on dealing ahead of the dissemination or publication of investment research.
Any trading symbols displayed are for illustrative purposes only and are not intended to portray recommendations.